Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Balarama K. Gundapaneni

Ziprasidone in Adolescents With Schizophrenia: Results From a Placebo-Controlled Efficacy and Long-Term Open-Extension Study

Journal of Child and Adolescent Psychopharmacology

English

Related publications

Long-Term Metformin Treatment in Adolescents With Obesity and Insulin Resistance, Results of an Open Label Extension Study

Nutrition and Diabetes

English

Efficacy and Safety of Duloxetine Versus Placebo in Adolescents With Juvenile Fibromyalgia: Results From a Randomized Controlled Trial

Pediatric Rheumatology

English

Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-To-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study

Arthritis and Rheumatology

English

Efficacy of Lanadelumab in Hereditary Angioedema Patients Switching From C1 Inhibitor Long-Term Prophylaxis: Interim Results From the HELP Open-Label Extension Study

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2019

English

Safety and Efficacy From an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents With Schizophrenia

Journal of Child and Adolescent Psychopharmacology

English

Long-Term Efficacy and Safety of RPC4046, an Anti-Interleukin-13 Monoclonal Antibody, in Patients With Eosinophilic Esophagitis: Results From the Open-Label Extension of the HEROES Study

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2019

English

Adalimumab for Nail Psoriasis: Efficacy and Safety From the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial

SKIN The Journal of Cutaneous Medicine

2017

English

Long-Term Safety and Tolerability of Oral Tofacitinib in Patients With Crohn’s Disease: Results From a Phase 2, Open-Label, 48-Week Extension Study

Alimentary Pharmacology and Therapeutics

English

Long-Term Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing’s Disease: Interim Results From a Long-Term Real-World Evidence Study

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Balarama K. Gundapaneni

Ziprasidone in Adolescents With Schizophrenia: Results From a Placebo-Controlled Efficacy and Long-Term Open-Extension Study

Related publications

Long-Term Metformin Treatment in Adolescents With Obesity and Insulin Resistance, Results of an Open Label Extension Study

Efficacy and Safety of Duloxetine Versus Placebo in Adolescents With Juvenile Fibromyalgia: Results From a Randomized Controlled Trial

Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-To-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study

Efficacy of Lanadelumab in Hereditary Angioedema Patients Switching From C1 Inhibitor Long-Term Prophylaxis: Interim Results From the HELP Open-Label Extension Study

Safety and Efficacy From an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents With Schizophrenia

Long-Term Efficacy and Safety of RPC4046, an Anti-Interleukin-13 Monoclonal Antibody, in Patients With Eosinophilic Esophagitis: Results From the Open-Label Extension of the HEROES Study

Adalimumab for Nail Psoriasis: Efficacy and Safety From the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial

Long-Term Safety and Tolerability of Oral Tofacitinib in Patients With Crohn’s Disease: Results From a Phase 2, Open-Label, 48-Week Extension Study

Long-Term Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing’s Disease: Interim Results From a Long-Term Real-World Evidence Study